LeMaitre Vascular Debt to Equity Ratio 2010-2025 | LMAT
Current and historical debt to equity ratio values for LeMaitre Vascular (LMAT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LeMaitre Vascular debt/equity for the three months ending March 31, 2025 was 0.48.
| LeMaitre Vascular Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.21B | $0.35B | 0.60 |
| 2024-12-31 | $0.22B | $0.34B | 0.64 |
| 2024-09-30 | $0.05B | $0.33B | 0.14 |
| 2024-06-30 | $0.04B | $0.32B | 0.14 |
| 2024-03-31 | $0.05B | $0.31B | 0.15 |
| 2023-12-31 | $0.05B | $0.30B | 0.16 |
| 2023-09-30 | $0.05B | $0.29B | 0.16 |
| 2023-06-30 | $0.04B | $0.28B | 0.15 |
| 2023-03-31 | $0.04B | $0.27B | 0.15 |
| 2022-12-31 | $0.04B | $0.27B | 0.16 |
| 2022-09-30 | $0.04B | $0.26B | 0.16 |
| 2022-06-30 | $0.04B | $0.26B | 0.16 |
| 2022-03-31 | $0.04B | $0.26B | 0.13 |
| 2021-12-31 | $0.04B | $0.25B | 0.15 |
| 2021-09-30 | $0.04B | $0.25B | 0.16 |
| 2021-06-30 | $0.06B | $0.19B | 0.33 |
| 2021-03-31 | $0.07B | $0.18B | 0.39 |
| 2020-12-31 | $0.08B | $0.17B | 0.47 |
| 2020-09-30 | $0.10B | $0.16B | 0.63 |
| 2020-06-30 | $0.10B | $0.15B | 0.68 |
| 2020-03-31 | $0.04B | $0.15B | 0.24 |
| 2019-12-31 | $0.04B | $0.15B | 0.27 |
| 2019-09-30 | $0.03B | $0.14B | 0.20 |
| 2019-06-30 | $0.03B | $0.14B | 0.18 |
| 2019-03-31 | $0.03B | $0.13B | 0.20 |
| 2018-12-31 | $0.02B | $0.13B | 0.18 |
| 2018-09-30 | $0.02B | $0.13B | 0.15 |
| 2018-06-30 | $0.02B | $0.12B | 0.14 |
| 2018-03-31 | $0.02B | $0.11B | 0.14 |
| 2017-12-31 | $0.02B | $0.11B | 0.15 |
| 2017-09-30 | $0.02B | $0.11B | 0.14 |
| 2017-06-30 | $0.01B | $0.10B | 0.14 |
| 2017-03-31 | $0.02B | $0.09B | 0.16 |
| 2016-12-31 | $0.01B | $0.09B | 0.17 |
| 2016-09-30 | $0.02B | $0.09B | 0.17 |
| 2016-06-30 | $0.01B | $0.08B | 0.15 |
| 2016-03-31 | $0.01B | $0.08B | 0.16 |
| 2015-12-31 | $0.01B | $0.08B | 0.17 |
| 2015-09-30 | $0.01B | $0.07B | 0.17 |
| 2015-06-30 | $0.01B | $0.07B | 0.18 |
| 2015-03-31 | $0.01B | $0.07B | 0.17 |
| 2014-12-31 | $0.01B | $0.07B | 0.20 |
| 2014-09-30 | $0.02B | $0.07B | 0.24 |
| 2014-06-30 | $0.01B | $0.07B | 0.19 |
| 2014-03-31 | $0.01B | $0.06B | 0.22 |
| 2013-12-31 | $0.01B | $0.06B | 0.25 |
| 2013-09-30 | $0.01B | $0.06B | 0.20 |
| 2013-06-30 | $0.01B | $0.05B | 0.18 |
| 2013-03-31 | $0.01B | $0.05B | 0.19 |
| 2012-12-31 | $0.01B | $0.05B | 0.19 |
| 2012-09-30 | $0.01B | $0.05B | 0.18 |
| 2012-06-30 | $0.01B | $0.05B | 0.15 |
| 2012-03-31 | $0.01B | $0.05B | 0.14 |
| 2011-12-31 | $0.01B | $0.05B | 0.15 |
| 2011-09-30 | $0.01B | $0.05B | 0.20 |
| 2011-06-30 | $0.01B | $0.05B | 0.17 |
| 2011-03-31 | $0.01B | $0.05B | 0.17 |
| 2010-12-31 | $0.01B | $0.05B | 0.21 |
| 2010-09-30 | $0.01B | $0.05B | 0.20 |
| 2010-06-30 | $0.01B | $0.05B | 0.18 |
| 2010-03-31 | $0.01B | $0.05B | 0.17 |
| 2009-12-31 | $0.01B | $0.05B | 0.18 |
| 2009-09-30 | $0.01B | $0.05B | 0.19 |
| 2009-06-30 | $0.01B | $0.05B | 0.18 |
| 2009-03-31 | $0.01B | $0.04B | 0.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.884B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.034B | 28.02 |
| Boston Scientific (BSX) | United States | $152.131B | 38.08 |
| Stryker (SYK) | United States | $146.225B | 30.58 |
| EssilorLuxottica (ESLOY) | France | $128.281B | 0.00 |
| Medtronic (MDT) | Ireland | $111.581B | 15.82 |
| Haleon (HLN) | United Kingdom | $50.069B | 28.51 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.244B | 0.00 |
| ResMed (RMD) | United States | $36.611B | 27.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.762B | 15.55 |
| Agilent Technologies (A) | United States | $32.366B | 21.10 |
| Terumo (TRUMY) | Japan | $26.576B | 34.52 |
| Insulet (PODD) | United States | $22.320B | 87.61 |
| Koninklijke Philips (PHG) | Netherlands | $21.929B | 15.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.186B | 11.68 |
| Baxter (BAX) | United States | $15.472B | 11.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.449B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.968B | 20.77 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 14.02 |
| Prestige Consumer Healthcare (PBH) | United States | $4.181B | 18.68 |
| Perrigo (PRGO) | Ireland | $3.570B | 9.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.382B | 15.40 |
| ICU Medical (ICUI) | United States | $3.271B | 24.12 |
| Envista Holdings (NVST) | United States | $3.166B | 26.31 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.022B | 13.91 |
| AtriCure (ATRC) | United States | $1.726B | 0.00 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.080B | 24.29 |
| Neogen (NEOG) | United States | $1.066B | 13.64 |
| Kestra Medical Technologies (KMTS) | United States | $1.025B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.38 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.633B | 0.00 |
| Evolus (EOLS) | United States | $0.628B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.602B | 0.00 |
| Owens & Minor (OMI) | United States | $0.588B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Valneva SE (VALN) | France | $0.525B | 0.00 |
| Surmodics (SRDX) | United States | $0.426B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.391B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.345B | 12.68 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 54.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.97 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.254B | 11.54 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| Biote (BTMD) | United States | $0.201B | 5.65 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.195B | 51.55 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| Agape ATP (ATPC) | $0.073B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.036B | 48.57 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |